Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Jean-Didier Cavallo is active.

Publication


Featured researches published by Jean-Didier Cavallo.


Antimicrobial Agents and Chemotherapy | 2002

Antibiotic Susceptibilities of 96 Isolates of Bacillus anthracis Isolated in France between 1994 and 2000

Jean-Didier Cavallo; Françoise Ramisse; Monique Girardet; Josée Vaissaire; Michelle Mock; Eric Hernandez

ABSTRACT Ninety-six isolates of Bacillus anthracis recovered in France between 1994 and 2000 were tested for their susceptibilities to 25 different antibiotics. Resistance to penicillin G and amoxicillin was 11.5%. All of the isolates were resistant to cotrimoxazole and susceptible to doxycycline, ciprofloxacin, pefloxacin, levofloxacin, teicoplanin, vancomycin, clindamycin, imipenem, and rifampin.


Antimicrobial Agents and Chemotherapy | 2001

Antibiotic Susceptibility and Mechanisms of Erythromycin Resistance in Clinical Isolates of Streptococcus agalactiae: French Multicenter Study

Dany De Mouy; Jean-Didier Cavallo; Roland Leclercq; Roland Fabre

ABSTRACT Among 126 Streptococcus agalactiae isolates collected in 10 French laboratories in 1999, 27 (21.4%) had macrolide resistance related to the presence of erm(B) (11 strains),erm(A) subclass erm(TR) (10 strains), andmef(A) genes (2 strains) and the presence of combinations of erm(B) and erm(A) genes ormef(A) genes (3 strains).


Medecine Et Maladies Infectieuses | 1998

Pseudomonas aeruginosa et infections urinaires en pratique de ville : étude AFORCOPIBIO 1995-1996

Jean-Didier Cavallo; D. de Mouy; Roland Fabre; E. Garrabe; M. Armengaud

Summary 32 P. aeruginosa strains were collected by ten private clinical laboratories in patients with community-acquired urinary tract infections during a prospective multicenter study performed during two 2-month periods (May and June) in 1995 and 1996. All non hospitalised patients in the past 3 months were included. Minimal inhibitory concentrations were determined by Mueller Hinton agar dilution for ticarcillin, piperacillin, ceftazidime, imipenem, ciprofloxacin, amikacin, and fosfomycin. Mechanisms of resistance were determined for all β-lactam resistant strains by iso-electric focusing, and when a strain did not produce penicillinase, the specific β-lactamase activity was quantified. P. aeruginosa was unfrequently isolated (1.5%). The highest rates of susceptibility were shown for ceftazidime and imipenem (respectively 96.9% and 90.6%). Susceptibility was lower for ticarcillin (50%), piperacillin (84.3%), fluoroquinolones (56.2%), amikacin (62.5%), and fosfomycin (62.5%). Two resistance mechanisms to β-lactams were involved in P. aeruginosa : non enzymatic resistance (9 strains) and production of penicillinase PSE-1 (7 strains).


Journal of Clinical Microbiology | 1998

Bacillus thuringiensis subsp. konkukian (Serotype H34) Superinfection: Case Report and Experimental Evidence of Pathogenicity in Immunosuppressed Mice

Eric Hernandez; Françoise Ramisse; Jean-Pierre Ducoureau; Thierry Cruel; Jean-Didier Cavallo


Fems Immunology and Medical Microbiology | 1999

Bacillus thuringiensis serotype H34 isolated from human and insecticidal strains serotypes 3a3b and H14 can lead to death of immunocompetent mice after pulmonary infection

Eric Hernandez; Franc°oise Ramisse; Thierry Cruel; Robert le Vagueresse; Jean-Didier Cavallo


Medecine Et Maladies Infectieuses | 2007

Infections urinaires communautaires de la femme de 15 à 65 ans : sensibilité aux antibiotiques de E. coli en fonction des antécédents : étude AFORCOPI–BIO 2003

D. de Mouy; Roland Fabre; Jean-Didier Cavallo


Fems Immunology and Medical Microbiology | 2000

Super‐infection by Bacillus thuringiensis H34 or 3a3b can lead to death in mice infected with the influenza A virus

Eric Hernandez; Franc°oise Ramisse; Philippe Gros; Jean-Didier Cavallo


Clinical Infectious Diseases | 1996

Disseminated Mycobacterium simiae infection in a patient with AIDS : Clinical features and treatment

Jean-Louis Koeck; T. Debord; Michel Fabre; V. Vincent; Jean-Didier Cavallo; R. Le Vagueresse


Fems Immunology and Medical Microbiology | 2000

Decreased virulence of a strain of Pseudomonas aeruginosa O12 overexpressing a chromosomal type 1 β‐lactamase could be due to reduced expression of cell‐to‐cell signaling dependent virulence factors

Franc°oise Ramisse; Christian van Delden; Stéphane Gidenne; Jean-Didier Cavallo; Eric Hernandez


Médecine tropicale | 1997

Antigénémie HRP-2 et paludisme d'importation à Plasmodium falciparum : Comparaison du ParaSight-F® et de l'ICT malaria P.f.®

Jean-Didier Cavallo; Eric Hernandez; Patrick Gérôme; N. Ploiton; T. Debord; R. Le Vagueresse

Collaboration


Dive into the Jean-Didier Cavallo's collaboration.

Top Co-Authors

Avatar

R. Labia

Centre national de la recherche scientifique

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge